No news there but comforting that boxes keep getting ticked.
Cash burn is slower than you might think for this sort of company.
I think the most interesting thing is this debt facility. I love that they are cognisant of shaeholder dilution with equity capital raises. Says that they are totally aligned with us.
I've been burned a few times on bio techs/device companies but I have a strong feeling that this one might be the business.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-2
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EBR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.09 |
Change
-0.065(5.65%) |
Mkt cap ! $348.1M | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.15 | $1.09 | $164.5K | 145.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 19833 | $1.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.12 | 5000 | 1 |
View Market Depth
| Last trade - 12.04pm 16/08/2024 (20 minute delay) ? |
| EBR (ASX) Chart |